Biobanking and Regulatory Readiness: Why Traceability Matters
In biobanking, storing a sample is only part of the challenge. Organisations also need confidence in what the sample is, where it has been, how it has been handled and whether its integrity has been maintained.
That makes traceability a fundamental part of effective sample management, particularly where materials support regulated research, pharmaceutical development, ATMPs, cell and gene therapy programmes or other GxP activities.
Traceability is more than knowing where a sample is
Good traceability connects a sample with the records that establish its history. Depending on the material and its intended use, those records can include:
sample identity and associated identifiers;
receipt and accession information;
storage location and movements;
storage conditions and relevant environmental records;
transfers, retrievals and returns;
handling or processing activities;
authorised personnel and recorded actions;
deviations or other quality events associated with the sample.
Together, these records help establish chain of custody, providing a documented history of the sample as responsibility or location changes.
Why this matters for regulatory readiness
When samples contribute to regulated activities, their value depends not only on their physical condition but also on confidence in the information associated with them.
A well-controlled biobanking process therefore needs to consider several interconnected areas:
Sample integrity
Appropriate storage and handling controls help maintain the condition of biological materials throughout their lifecycle.
Data integrity
Sample records should remain attributable and reliable, allowing organisations to understand what happened to a sample and when.
Chain of custody
Documented transfers and movements provide continuity between receipt, storage, retrieval and onward use.
Environmental control
Where defined storage conditions are required, monitoring and associated records provide evidence of the environment in which materials have been maintained.
Quality management
Procedures, controlled records, deviations, change control and appropriate oversight help make traceability part of a wider quality system rather than an isolated administrative exercise.
These controls can make it easier to reconstruct a sample's lifecycle during an internal review, customer audit or regulatory inspection.
The operational value of traceability
Traceability is not solely about inspection readiness.
Consider a sample retrieved several years after it entered storage. The scientific team may need to establish its precise identity, storage history and previous movements before deciding whether it is appropriate for the next stage of work.
If that information is dispersed across spreadsheets, paper records and disconnected systems, the investigation becomes considerably more difficult.
A coherent sample-management process provides a clearer evidence trail. This can support better-informed decisions, more efficient investigations and continuity as programmes, personnel and organisations change.
Building traceability into biobanking
For biotechnology and pharmaceutical organisations, useful questions to ask include:
Can every sample be uniquely identified throughout its lifecycle?
Can its location and movement history be reconstructed?
Are relevant storage conditions monitored and recorded?
Are records protected through appropriate data-integrity controls?
Are exceptions and deviations documented and managed through the quality system?
Can records be retrieved efficiently when needed for an audit, investigation or programme decision?
These questions help shift the emphasis from simply storing biological material to maintaining samples within a controlled and documented lifecycle.
How Advent BioServices can help
Advent BioServices supports biotechnology, pharmaceutical and advanced-therapy organisations with GMP-compliant biobanking, sample storage and management, and cryogenic storage, alongside broader quality and laboratory support.
The objective is practical: to help clients maintain appropriate control over important biological materials while supporting traceability, sample integrity and regulatory readiness throughout their programmes.
For organisations reviewing their current biobanking arrangements, it can be useful to look beyond freezer capacity and temperature alone.
How readily you can demonstrate the history and control of each sample may be just as important as where it is stored.
If you are reviewing your biobanking or sample-management strategy, speak to Advent BioServices about the controls and support appropriate for your programme.